Inhibition of the Key Glycolytic Enzyme PFKFB3 with Novel Compounds Suppresses Angiogenesis

被引：0
|
作者：
Abdali, Anahita
Corsini, Alberto
Baci, Denisa
De Dominicis, Carlo
Zanda, Matteo
Gelmi, Maria Luisa
Bellosta, Stefano
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2018年 / 38卷
关键词：
D O I：
10.1161/atvb.38.suppl_1.605
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
605
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inhibition of the Key Glycolytic Enzyme PFKFB3 with Novel Compounds Suppresses Angiogenesis
    Abdali, Anahita
    Corsini, Alberto
    Baci, Denisa
    De Dominicis, Carlo
    Zanda, Matteo
    Gelmi, Maria Luisa
    Bellosta, Stefano
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [2] ANGIOGENESIS INHIBITION WITH NOVEL COMPOUNDS TARGETING THE KEY GLYCOLYTIC ENZYME PFKFB3
    Abdali, A.
    Corsini, A.
    Baci, D.
    De Dominicis, C.
    Zanda, M.
    Gelmi, M. L.
    Bellosta, S.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E127 - E127
  • [3] In vitro angiogenesis inhibition with selective compounds targeting the key glycolytic enzyme PFKFB3
    Abdali, Anahita
    Baci, Denisa
    Damiani, Isabella
    Belloni, Federica
    De Dominicis, Carlo
    Gelmi, Maria Luisa
    Corsini, Alberto
    Bellosta, Stefano
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 168
  • [4] The glycolytic enzyme PFKFB3/phosphofructokinase regulates autophagy
    Yang, Zhen
    Goronzy, Joerg J.
    Weyand, Cornelia M.
    [J]. AUTOPHAGY, 2014, 10 (02) : 382 - 383
  • [5] PFKFB3: A Potential Key to Ocular Angiogenesis
    Zhou, Zi-Yi
    Wang, Lin
    Wang, Yu-Sheng
    Dou, Guo-Rui
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [6] PARTIAL MYELOID INHIBITION OF KEY GLYCOLYTIC ENZYME PFKFB3 INCREASES HEPATIC STEATOSIS AND INFLAMMATION, BUT DOES NOT AFFECT ATHEROSCLEROSIS
    Tillie, R.
    De Bruijn, J.
    Dobie, R.
    Perales-Paton, J.
    Van Kuijk, K.
    Gijbels, M.
    Temmerman, L.
    Ghosheh, Y.
    Goossens, G.
    Carmeliet, P.
    Ley, K.
    Henderson, N.
    Saez-Rodriguez, J.
    Wouters, K.
    Sluimer, J.
    [J]. ATHEROSCLEROSIS, 2023, 379
  • [7] Pharmacological PFKFB3 inhibition influences tumor angiogenesis
    Khodova, K.
    Eremeeva, T.
    Shishov, D.
    Fedichev, P.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1
    Trenti, Annalisa
    Tedesco, Serena
    Boscaro, Carlotta
    Ferri, Nicola
    Cignarella, Andrea
    Trevisi, Lucia
    Bolego, Chiara
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (03): : 398 - 407
  • [9] Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma
    Matsumoto, Kenichi
    Noda, Takehiro
    Kobayashi, Shogo
    Sakano, Yoshihiro
    Yokota, Yuki
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Tomimaru, Yoshito
    Akita, Hirofumi
    Gotoh, Kunihito
    Takeda, Yutaka
    Tanemura, Masahiro
    Umeshita, Koji
    Doki, Yuichiro
    Eguchi, Hidetoshi
    [J]. CANCER LETTERS, 2021, 500 : 29 - 40
  • [10] Partial Inhibition of the Key Glycolytic Enzyme PFKFB3 in Myeloid Cells Impacts Whole-Body Immune Cell and Liver Metabolism, But Not Atherogenesis
    de Bruijn, Jenny
    van Kuijk, Kim
    Bijnen, Mitchell
    Sander, Bianca
    Gijbels, Marion
    Carmeliet, Peter
    Wouters, Kristiaan
    Sluimer, Judith C.
    [J]. JOURNAL OF VASCULAR RESEARCH, 2019, 56 : 24 - 24
12345